(a) Logistic analyses modeling responses of “likely” or “very likely” to participate in clinical trials; (b) logistic analyses modeling responses of “likely” or “very likely” to participate in observational research.
(a) . | ||||||
---|---|---|---|---|---|---|
Type . | Clinical drug trial . | Clinical drug trial with biospecimen collection research . | Clinical drug trial research including colonoscopy . | |||
% likely or very likely | 51 | 64 | 38 |
(a) . | ||||||
---|---|---|---|---|---|---|
Type . | Clinical drug trial . | Clinical drug trial with biospecimen collection research . | Clinical drug trial research including colonoscopy . | |||
% likely or very likely | 51 | 64 | 38 |
Predictors . | OR (95% CI) . | P . | OR (95% CI) . | P . | OR (95% CI) . | P . |
---|---|---|---|---|---|---|
Age | 1.01 (0.99-1.02) | .30 | 1.01 (0.99-1.03) | .31 | 1.00 (0.98-1.02) | .92 |
IBD | ||||||
Other | 0.95 (0.59-1.55) | .84 | 0.83 (0.49-1.4) | .48 | 0.85 (0.52-1.40) | .52 |
UC | 1.00 (0.75-1.34) | .99 | 0.78 (0.57-1.06) | .11 | 1.21 (0.90-1.63) | .21 |
CD | ref | ref | ref | |||
Education | 1.00 (0.89-1.14) | .95 | 1.04 (0.91-1.18) | .61 | 1.06 (0.94-1.21) | .34 |
Income | 0.98 (0.91-1.07) | .71 | 1.09 (0.99-1.19) | .068 | 0.99 (0.91-1.08) | .88 |
Awareness | ||||||
Very | ref | ref | ref | |||
Somewhat | 0.72 (0.51-1.03) | .072 | 0.77 (0.52-1.13) | .19 | 0.69 (0.49-0.98) | .037 |
None | 0.51 (0.33-0.77) | .0015 | 0.46 (0.3-0.72) | .0007 | 0.54 (0.35-0.82) | .0044 |
Previous trials (Y vs N) | 1.65 (1.21-2.26) | .0018 | 1.58 (1.12-2.22) | .0097 | 1.32 (0.97-1.8) | .081 |
Reason | ||||||
Access to experts | 0.88 (0.43-1.81) | .72 | 0.62 (0.3-1.3) | .2066 | 0.47 (0.2-1.09) | .077 |
Doctor recommendation | 0.51 (0.24-1.06) | .069 | 0.34 (0.16-0.7) | .0037 | 0.59 (0.27-1.28) | .18 |
Improve my life | 1.21 (0.86-1.70) | .28 | 1 (0.7-1.45) | .99 | 1.01 (0.72-1.43) | .96 |
Newest therapies | 1.14 (0.6-2.17) | .68 | 0.57 (0.29-1.1) | .0909 | 1.11 (0.59-2.1) | .75 |
New-to-me therapies | 1.11 (0.53-2.33) | .79 | 1.11 (0.49-2.51) | .81 | 1.43 (0.69-2.96) | .33 |
More tests | 1.00 (0.42-2.41) | 1.00 | 1.72 (0.6-4.96) | .31 | 1.53 (0.63-3.71) | .35 |
Other | 0.39 (0.20-0.76) | .0056 | 0.51 (0.26-0.97) | .042 | 0.65 (0.33-1.27) | .21 |
Increase knowledge | ref | ref | ref | |||
Male | 1.22 (0.91-1.62) | .18 | 0.81 (0.60-1.10) | .18 | 1.28 (0.96-1.71) | .10 |
Receiving results | ||||||
Eventually | 0.86 (0.62-1.19) | .37 | 0.68 (0.48-0.96) | .029 | 0.69 (0.5-0.96) | .027 |
within 6 months | 0.67 (0.4-1.15) | .15 | 0.47 (0.27-0.82) | .0077 | 0.74 (0.43-1.28) | .27 |
within 1 year | 0.8 (0.53-1.22) | .31 | 0.61 (0.39-0.94) | .026 | 0.6 (0.39-0.93) | .022 |
don’t care | ref | ref | ref | |||
Comorbidities (Y vs N) | 0.99 (0.73-1.34) | .95 | 0.86 (0.62-1.19) | .37 | 0.99 (0.73-1.35) | .97 |
Depression/anxiety (Y vs N) | 0.92 (0.67-1.27) | .61 | 1.28 (0.9-1.81) | .17 | 1.07 (0.77-1.48) | .69 |
Employment | ||||||
Other vs full-time | 0.81 (0.54-1.22) | .32 | 1.13 (0.73-1.75) | .58 | 1.46 (0.97-2.19) | .072 |
Retired vs full-time | 0.9 (0.58-1.38) | .63 | 1.07 (0.68-1.69) | .77 | 1.26 (0.81-1.94) | .30 |
Predictors . | OR (95% CI) . | P . | OR (95% CI) . | P . | OR (95% CI) . | P . |
---|---|---|---|---|---|---|
Age | 1.01 (0.99-1.02) | .30 | 1.01 (0.99-1.03) | .31 | 1.00 (0.98-1.02) | .92 |
IBD | ||||||
Other | 0.95 (0.59-1.55) | .84 | 0.83 (0.49-1.4) | .48 | 0.85 (0.52-1.40) | .52 |
UC | 1.00 (0.75-1.34) | .99 | 0.78 (0.57-1.06) | .11 | 1.21 (0.90-1.63) | .21 |
CD | ref | ref | ref | |||
Education | 1.00 (0.89-1.14) | .95 | 1.04 (0.91-1.18) | .61 | 1.06 (0.94-1.21) | .34 |
Income | 0.98 (0.91-1.07) | .71 | 1.09 (0.99-1.19) | .068 | 0.99 (0.91-1.08) | .88 |
Awareness | ||||||
Very | ref | ref | ref | |||
Somewhat | 0.72 (0.51-1.03) | .072 | 0.77 (0.52-1.13) | .19 | 0.69 (0.49-0.98) | .037 |
None | 0.51 (0.33-0.77) | .0015 | 0.46 (0.3-0.72) | .0007 | 0.54 (0.35-0.82) | .0044 |
Previous trials (Y vs N) | 1.65 (1.21-2.26) | .0018 | 1.58 (1.12-2.22) | .0097 | 1.32 (0.97-1.8) | .081 |
Reason | ||||||
Access to experts | 0.88 (0.43-1.81) | .72 | 0.62 (0.3-1.3) | .2066 | 0.47 (0.2-1.09) | .077 |
Doctor recommendation | 0.51 (0.24-1.06) | .069 | 0.34 (0.16-0.7) | .0037 | 0.59 (0.27-1.28) | .18 |
Improve my life | 1.21 (0.86-1.70) | .28 | 1 (0.7-1.45) | .99 | 1.01 (0.72-1.43) | .96 |
Newest therapies | 1.14 (0.6-2.17) | .68 | 0.57 (0.29-1.1) | .0909 | 1.11 (0.59-2.1) | .75 |
New-to-me therapies | 1.11 (0.53-2.33) | .79 | 1.11 (0.49-2.51) | .81 | 1.43 (0.69-2.96) | .33 |
More tests | 1.00 (0.42-2.41) | 1.00 | 1.72 (0.6-4.96) | .31 | 1.53 (0.63-3.71) | .35 |
Other | 0.39 (0.20-0.76) | .0056 | 0.51 (0.26-0.97) | .042 | 0.65 (0.33-1.27) | .21 |
Increase knowledge | ref | ref | ref | |||
Male | 1.22 (0.91-1.62) | .18 | 0.81 (0.60-1.10) | .18 | 1.28 (0.96-1.71) | .10 |
Receiving results | ||||||
Eventually | 0.86 (0.62-1.19) | .37 | 0.68 (0.48-0.96) | .029 | 0.69 (0.5-0.96) | .027 |
within 6 months | 0.67 (0.4-1.15) | .15 | 0.47 (0.27-0.82) | .0077 | 0.74 (0.43-1.28) | .27 |
within 1 year | 0.8 (0.53-1.22) | .31 | 0.61 (0.39-0.94) | .026 | 0.6 (0.39-0.93) | .022 |
don’t care | ref | ref | ref | |||
Comorbidities (Y vs N) | 0.99 (0.73-1.34) | .95 | 0.86 (0.62-1.19) | .37 | 0.99 (0.73-1.35) | .97 |
Depression/anxiety (Y vs N) | 0.92 (0.67-1.27) | .61 | 1.28 (0.9-1.81) | .17 | 1.07 (0.77-1.48) | .69 |
Employment | ||||||
Other vs full-time | 0.81 (0.54-1.22) | .32 | 1.13 (0.73-1.75) | .58 | 1.46 (0.97-2.19) | .072 |
Retired vs full-time | 0.9 (0.58-1.38) | .63 | 1.07 (0.68-1.69) | .77 | 1.26 (0.81-1.94) | .30 |
(b) . | ||||||
---|---|---|---|---|---|---|
Type . | Research using health records . | Research using records & specimens . | ||||
% likely or very likely | 85 | 71 |
(b) . | ||||||
---|---|---|---|---|---|---|
Type . | Research using health records . | Research using records & specimens . | ||||
% likely or very likely | 85 | 71 |
Predictors . | OR (95% CI) . | P . | OR (95% CI) . | P . | ||
---|---|---|---|---|---|---|
Age | 1.00 (0.97-1.02) | .68 | 1.00 (0.98-1.02) | .88 | ||
IBD | ||||||
Other | 1.11 (0.50-2.46) | .80 | 0.89 (0.51-1.54) | |||
UC | 0.81 (0.52-1.27) | .37 | 0.84 (0.61-1.17) | .30 | ||
CD | ref | ref | ||||
Education | 1.05 (0.87-1.27) | .59 | 1.01 (0.88-1.16) | .87 | ||
Income | 1.02 (0.90-1.16) | .74 | 1.02 (0.93-1.12) | .67 | ||
Awareness | ||||||
Very | Ref | ref | ||||
Somewhat | 0.47 (0.25-0.87) | .017 | 0.90 (0.60-1.35) | .61 | ||
None | 0.31 (0.16-0.63) | .0011 | 0.62 (0.39-0.98) | .041 | ||
Previous trials (Y vs N) | 0.60 (0.37-0.95) | .030 | 1.2 (0.84-1.71) | .33 | ||
Reason | ||||||
Access to experts | 0.53 (0.22-1.29) | .16 | 0.98 (0.45-2.12) | .96 | ||
Doctor recommendation | 0.98 (0.35-2.76) | .96 | 0.49 (0.24-1) | .051 | ||
Improve my life | 0.98 (0.57-1.67) | .94 | 1.13 (0.76-1.66) | .55 | ||
Newest therapies | 0.76 (0.30-1.89) | .55 | 1.01 (0.49-2.07) | .98 | ||
New-to-me therapies | 0.82 (0.26-2.51) | .72 | 1.10 (0.47-2.56) | .83 | ||
More tests | 1.16 (0.25-5.34) | .85 | 1.01 (0.38-2.74) | .98 | ||
Other | 0.54 (0.23-1.30) | .17 | 0.80 (0.40-1.60) | .53 | ||
Increase knowledge | ref | ref | ||||
Male | 0.75 (0.49-1.16) | .20 | 0.84 (0.61-1.16) | .29 | ||
Receiving results | ||||||
eventually | 0.70 (0.41-1.18) | .18 | 0.73 (0.50-1.06) | .094 | ||
within 6 months | 0.28 (0.15-0.54) | .0002 | 0.39 (0.23-0.68) | .0009 | ||
within 1 year | 0.60 (0.32-1.13) | .11 | 0.57 (0.36-0.90) | .015 | ||
don’t care | ref | ref | ||||
Comorbidities (Y vs N) | 0.93 (0.59-1.47) | .75 | 0.96 (0.68-1.34) | .79 | ||
Depression/anxiety (Y vs N) | 0.70 (0.44-1.12) | .14 | 0.83 (0.58-1.18) | .30 | ||
Employment | ||||||
Other vs full-time | 1.62 (0.81-3.26) | .18 | 1.44 (0.90-2.30) | .13 | ||
Retired vs full-time | 1.08 (0.56-2.1) | .81 | 1.17 (0.72-1.88) | .53 |
Predictors . | OR (95% CI) . | P . | OR (95% CI) . | P . | ||
---|---|---|---|---|---|---|
Age | 1.00 (0.97-1.02) | .68 | 1.00 (0.98-1.02) | .88 | ||
IBD | ||||||
Other | 1.11 (0.50-2.46) | .80 | 0.89 (0.51-1.54) | |||
UC | 0.81 (0.52-1.27) | .37 | 0.84 (0.61-1.17) | .30 | ||
CD | ref | ref | ||||
Education | 1.05 (0.87-1.27) | .59 | 1.01 (0.88-1.16) | .87 | ||
Income | 1.02 (0.90-1.16) | .74 | 1.02 (0.93-1.12) | .67 | ||
Awareness | ||||||
Very | Ref | ref | ||||
Somewhat | 0.47 (0.25-0.87) | .017 | 0.90 (0.60-1.35) | .61 | ||
None | 0.31 (0.16-0.63) | .0011 | 0.62 (0.39-0.98) | .041 | ||
Previous trials (Y vs N) | 0.60 (0.37-0.95) | .030 | 1.2 (0.84-1.71) | .33 | ||
Reason | ||||||
Access to experts | 0.53 (0.22-1.29) | .16 | 0.98 (0.45-2.12) | .96 | ||
Doctor recommendation | 0.98 (0.35-2.76) | .96 | 0.49 (0.24-1) | .051 | ||
Improve my life | 0.98 (0.57-1.67) | .94 | 1.13 (0.76-1.66) | .55 | ||
Newest therapies | 0.76 (0.30-1.89) | .55 | 1.01 (0.49-2.07) | .98 | ||
New-to-me therapies | 0.82 (0.26-2.51) | .72 | 1.10 (0.47-2.56) | .83 | ||
More tests | 1.16 (0.25-5.34) | .85 | 1.01 (0.38-2.74) | .98 | ||
Other | 0.54 (0.23-1.30) | .17 | 0.80 (0.40-1.60) | .53 | ||
Increase knowledge | ref | ref | ||||
Male | 0.75 (0.49-1.16) | .20 | 0.84 (0.61-1.16) | .29 | ||
Receiving results | ||||||
eventually | 0.70 (0.41-1.18) | .18 | 0.73 (0.50-1.06) | .094 | ||
within 6 months | 0.28 (0.15-0.54) | .0002 | 0.39 (0.23-0.68) | .0009 | ||
within 1 year | 0.60 (0.32-1.13) | .11 | 0.57 (0.36-0.90) | .015 | ||
don’t care | ref | ref | ||||
Comorbidities (Y vs N) | 0.93 (0.59-1.47) | .75 | 0.96 (0.68-1.34) | .79 | ||
Depression/anxiety (Y vs N) | 0.70 (0.44-1.12) | .14 | 0.83 (0.58-1.18) | .30 | ||
Employment | ||||||
Other vs full-time | 1.62 (0.81-3.26) | .18 | 1.44 (0.90-2.30) | .13 | ||
Retired vs full-time | 1.08 (0.56-2.1) | .81 | 1.17 (0.72-1.88) | .53 |
(a) Logistic analyses modeling responses of “likely” or “very likely” to participate in clinical trials; (b) logistic analyses modeling responses of “likely” or “very likely” to participate in observational research.
(a) . | ||||||
---|---|---|---|---|---|---|
Type . | Clinical drug trial . | Clinical drug trial with biospecimen collection research . | Clinical drug trial research including colonoscopy . | |||
% likely or very likely | 51 | 64 | 38 |
(a) . | ||||||
---|---|---|---|---|---|---|
Type . | Clinical drug trial . | Clinical drug trial with biospecimen collection research . | Clinical drug trial research including colonoscopy . | |||
% likely or very likely | 51 | 64 | 38 |
Predictors . | OR (95% CI) . | P . | OR (95% CI) . | P . | OR (95% CI) . | P . |
---|---|---|---|---|---|---|
Age | 1.01 (0.99-1.02) | .30 | 1.01 (0.99-1.03) | .31 | 1.00 (0.98-1.02) | .92 |
IBD | ||||||
Other | 0.95 (0.59-1.55) | .84 | 0.83 (0.49-1.4) | .48 | 0.85 (0.52-1.40) | .52 |
UC | 1.00 (0.75-1.34) | .99 | 0.78 (0.57-1.06) | .11 | 1.21 (0.90-1.63) | .21 |
CD | ref | ref | ref | |||
Education | 1.00 (0.89-1.14) | .95 | 1.04 (0.91-1.18) | .61 | 1.06 (0.94-1.21) | .34 |
Income | 0.98 (0.91-1.07) | .71 | 1.09 (0.99-1.19) | .068 | 0.99 (0.91-1.08) | .88 |
Awareness | ||||||
Very | ref | ref | ref | |||
Somewhat | 0.72 (0.51-1.03) | .072 | 0.77 (0.52-1.13) | .19 | 0.69 (0.49-0.98) | .037 |
None | 0.51 (0.33-0.77) | .0015 | 0.46 (0.3-0.72) | .0007 | 0.54 (0.35-0.82) | .0044 |
Previous trials (Y vs N) | 1.65 (1.21-2.26) | .0018 | 1.58 (1.12-2.22) | .0097 | 1.32 (0.97-1.8) | .081 |
Reason | ||||||
Access to experts | 0.88 (0.43-1.81) | .72 | 0.62 (0.3-1.3) | .2066 | 0.47 (0.2-1.09) | .077 |
Doctor recommendation | 0.51 (0.24-1.06) | .069 | 0.34 (0.16-0.7) | .0037 | 0.59 (0.27-1.28) | .18 |
Improve my life | 1.21 (0.86-1.70) | .28 | 1 (0.7-1.45) | .99 | 1.01 (0.72-1.43) | .96 |
Newest therapies | 1.14 (0.6-2.17) | .68 | 0.57 (0.29-1.1) | .0909 | 1.11 (0.59-2.1) | .75 |
New-to-me therapies | 1.11 (0.53-2.33) | .79 | 1.11 (0.49-2.51) | .81 | 1.43 (0.69-2.96) | .33 |
More tests | 1.00 (0.42-2.41) | 1.00 | 1.72 (0.6-4.96) | .31 | 1.53 (0.63-3.71) | .35 |
Other | 0.39 (0.20-0.76) | .0056 | 0.51 (0.26-0.97) | .042 | 0.65 (0.33-1.27) | .21 |
Increase knowledge | ref | ref | ref | |||
Male | 1.22 (0.91-1.62) | .18 | 0.81 (0.60-1.10) | .18 | 1.28 (0.96-1.71) | .10 |
Receiving results | ||||||
Eventually | 0.86 (0.62-1.19) | .37 | 0.68 (0.48-0.96) | .029 | 0.69 (0.5-0.96) | .027 |
within 6 months | 0.67 (0.4-1.15) | .15 | 0.47 (0.27-0.82) | .0077 | 0.74 (0.43-1.28) | .27 |
within 1 year | 0.8 (0.53-1.22) | .31 | 0.61 (0.39-0.94) | .026 | 0.6 (0.39-0.93) | .022 |
don’t care | ref | ref | ref | |||
Comorbidities (Y vs N) | 0.99 (0.73-1.34) | .95 | 0.86 (0.62-1.19) | .37 | 0.99 (0.73-1.35) | .97 |
Depression/anxiety (Y vs N) | 0.92 (0.67-1.27) | .61 | 1.28 (0.9-1.81) | .17 | 1.07 (0.77-1.48) | .69 |
Employment | ||||||
Other vs full-time | 0.81 (0.54-1.22) | .32 | 1.13 (0.73-1.75) | .58 | 1.46 (0.97-2.19) | .072 |
Retired vs full-time | 0.9 (0.58-1.38) | .63 | 1.07 (0.68-1.69) | .77 | 1.26 (0.81-1.94) | .30 |
Predictors . | OR (95% CI) . | P . | OR (95% CI) . | P . | OR (95% CI) . | P . |
---|---|---|---|---|---|---|
Age | 1.01 (0.99-1.02) | .30 | 1.01 (0.99-1.03) | .31 | 1.00 (0.98-1.02) | .92 |
IBD | ||||||
Other | 0.95 (0.59-1.55) | .84 | 0.83 (0.49-1.4) | .48 | 0.85 (0.52-1.40) | .52 |
UC | 1.00 (0.75-1.34) | .99 | 0.78 (0.57-1.06) | .11 | 1.21 (0.90-1.63) | .21 |
CD | ref | ref | ref | |||
Education | 1.00 (0.89-1.14) | .95 | 1.04 (0.91-1.18) | .61 | 1.06 (0.94-1.21) | .34 |
Income | 0.98 (0.91-1.07) | .71 | 1.09 (0.99-1.19) | .068 | 0.99 (0.91-1.08) | .88 |
Awareness | ||||||
Very | ref | ref | ref | |||
Somewhat | 0.72 (0.51-1.03) | .072 | 0.77 (0.52-1.13) | .19 | 0.69 (0.49-0.98) | .037 |
None | 0.51 (0.33-0.77) | .0015 | 0.46 (0.3-0.72) | .0007 | 0.54 (0.35-0.82) | .0044 |
Previous trials (Y vs N) | 1.65 (1.21-2.26) | .0018 | 1.58 (1.12-2.22) | .0097 | 1.32 (0.97-1.8) | .081 |
Reason | ||||||
Access to experts | 0.88 (0.43-1.81) | .72 | 0.62 (0.3-1.3) | .2066 | 0.47 (0.2-1.09) | .077 |
Doctor recommendation | 0.51 (0.24-1.06) | .069 | 0.34 (0.16-0.7) | .0037 | 0.59 (0.27-1.28) | .18 |
Improve my life | 1.21 (0.86-1.70) | .28 | 1 (0.7-1.45) | .99 | 1.01 (0.72-1.43) | .96 |
Newest therapies | 1.14 (0.6-2.17) | .68 | 0.57 (0.29-1.1) | .0909 | 1.11 (0.59-2.1) | .75 |
New-to-me therapies | 1.11 (0.53-2.33) | .79 | 1.11 (0.49-2.51) | .81 | 1.43 (0.69-2.96) | .33 |
More tests | 1.00 (0.42-2.41) | 1.00 | 1.72 (0.6-4.96) | .31 | 1.53 (0.63-3.71) | .35 |
Other | 0.39 (0.20-0.76) | .0056 | 0.51 (0.26-0.97) | .042 | 0.65 (0.33-1.27) | .21 |
Increase knowledge | ref | ref | ref | |||
Male | 1.22 (0.91-1.62) | .18 | 0.81 (0.60-1.10) | .18 | 1.28 (0.96-1.71) | .10 |
Receiving results | ||||||
Eventually | 0.86 (0.62-1.19) | .37 | 0.68 (0.48-0.96) | .029 | 0.69 (0.5-0.96) | .027 |
within 6 months | 0.67 (0.4-1.15) | .15 | 0.47 (0.27-0.82) | .0077 | 0.74 (0.43-1.28) | .27 |
within 1 year | 0.8 (0.53-1.22) | .31 | 0.61 (0.39-0.94) | .026 | 0.6 (0.39-0.93) | .022 |
don’t care | ref | ref | ref | |||
Comorbidities (Y vs N) | 0.99 (0.73-1.34) | .95 | 0.86 (0.62-1.19) | .37 | 0.99 (0.73-1.35) | .97 |
Depression/anxiety (Y vs N) | 0.92 (0.67-1.27) | .61 | 1.28 (0.9-1.81) | .17 | 1.07 (0.77-1.48) | .69 |
Employment | ||||||
Other vs full-time | 0.81 (0.54-1.22) | .32 | 1.13 (0.73-1.75) | .58 | 1.46 (0.97-2.19) | .072 |
Retired vs full-time | 0.9 (0.58-1.38) | .63 | 1.07 (0.68-1.69) | .77 | 1.26 (0.81-1.94) | .30 |
(b) . | ||||||
---|---|---|---|---|---|---|
Type . | Research using health records . | Research using records & specimens . | ||||
% likely or very likely | 85 | 71 |
(b) . | ||||||
---|---|---|---|---|---|---|
Type . | Research using health records . | Research using records & specimens . | ||||
% likely or very likely | 85 | 71 |
Predictors . | OR (95% CI) . | P . | OR (95% CI) . | P . | ||
---|---|---|---|---|---|---|
Age | 1.00 (0.97-1.02) | .68 | 1.00 (0.98-1.02) | .88 | ||
IBD | ||||||
Other | 1.11 (0.50-2.46) | .80 | 0.89 (0.51-1.54) | |||
UC | 0.81 (0.52-1.27) | .37 | 0.84 (0.61-1.17) | .30 | ||
CD | ref | ref | ||||
Education | 1.05 (0.87-1.27) | .59 | 1.01 (0.88-1.16) | .87 | ||
Income | 1.02 (0.90-1.16) | .74 | 1.02 (0.93-1.12) | .67 | ||
Awareness | ||||||
Very | Ref | ref | ||||
Somewhat | 0.47 (0.25-0.87) | .017 | 0.90 (0.60-1.35) | .61 | ||
None | 0.31 (0.16-0.63) | .0011 | 0.62 (0.39-0.98) | .041 | ||
Previous trials (Y vs N) | 0.60 (0.37-0.95) | .030 | 1.2 (0.84-1.71) | .33 | ||
Reason | ||||||
Access to experts | 0.53 (0.22-1.29) | .16 | 0.98 (0.45-2.12) | .96 | ||
Doctor recommendation | 0.98 (0.35-2.76) | .96 | 0.49 (0.24-1) | .051 | ||
Improve my life | 0.98 (0.57-1.67) | .94 | 1.13 (0.76-1.66) | .55 | ||
Newest therapies | 0.76 (0.30-1.89) | .55 | 1.01 (0.49-2.07) | .98 | ||
New-to-me therapies | 0.82 (0.26-2.51) | .72 | 1.10 (0.47-2.56) | .83 | ||
More tests | 1.16 (0.25-5.34) | .85 | 1.01 (0.38-2.74) | .98 | ||
Other | 0.54 (0.23-1.30) | .17 | 0.80 (0.40-1.60) | .53 | ||
Increase knowledge | ref | ref | ||||
Male | 0.75 (0.49-1.16) | .20 | 0.84 (0.61-1.16) | .29 | ||
Receiving results | ||||||
eventually | 0.70 (0.41-1.18) | .18 | 0.73 (0.50-1.06) | .094 | ||
within 6 months | 0.28 (0.15-0.54) | .0002 | 0.39 (0.23-0.68) | .0009 | ||
within 1 year | 0.60 (0.32-1.13) | .11 | 0.57 (0.36-0.90) | .015 | ||
don’t care | ref | ref | ||||
Comorbidities (Y vs N) | 0.93 (0.59-1.47) | .75 | 0.96 (0.68-1.34) | .79 | ||
Depression/anxiety (Y vs N) | 0.70 (0.44-1.12) | .14 | 0.83 (0.58-1.18) | .30 | ||
Employment | ||||||
Other vs full-time | 1.62 (0.81-3.26) | .18 | 1.44 (0.90-2.30) | .13 | ||
Retired vs full-time | 1.08 (0.56-2.1) | .81 | 1.17 (0.72-1.88) | .53 |
Predictors . | OR (95% CI) . | P . | OR (95% CI) . | P . | ||
---|---|---|---|---|---|---|
Age | 1.00 (0.97-1.02) | .68 | 1.00 (0.98-1.02) | .88 | ||
IBD | ||||||
Other | 1.11 (0.50-2.46) | .80 | 0.89 (0.51-1.54) | |||
UC | 0.81 (0.52-1.27) | .37 | 0.84 (0.61-1.17) | .30 | ||
CD | ref | ref | ||||
Education | 1.05 (0.87-1.27) | .59 | 1.01 (0.88-1.16) | .87 | ||
Income | 1.02 (0.90-1.16) | .74 | 1.02 (0.93-1.12) | .67 | ||
Awareness | ||||||
Very | Ref | ref | ||||
Somewhat | 0.47 (0.25-0.87) | .017 | 0.90 (0.60-1.35) | .61 | ||
None | 0.31 (0.16-0.63) | .0011 | 0.62 (0.39-0.98) | .041 | ||
Previous trials (Y vs N) | 0.60 (0.37-0.95) | .030 | 1.2 (0.84-1.71) | .33 | ||
Reason | ||||||
Access to experts | 0.53 (0.22-1.29) | .16 | 0.98 (0.45-2.12) | .96 | ||
Doctor recommendation | 0.98 (0.35-2.76) | .96 | 0.49 (0.24-1) | .051 | ||
Improve my life | 0.98 (0.57-1.67) | .94 | 1.13 (0.76-1.66) | .55 | ||
Newest therapies | 0.76 (0.30-1.89) | .55 | 1.01 (0.49-2.07) | .98 | ||
New-to-me therapies | 0.82 (0.26-2.51) | .72 | 1.10 (0.47-2.56) | .83 | ||
More tests | 1.16 (0.25-5.34) | .85 | 1.01 (0.38-2.74) | .98 | ||
Other | 0.54 (0.23-1.30) | .17 | 0.80 (0.40-1.60) | .53 | ||
Increase knowledge | ref | ref | ||||
Male | 0.75 (0.49-1.16) | .20 | 0.84 (0.61-1.16) | .29 | ||
Receiving results | ||||||
eventually | 0.70 (0.41-1.18) | .18 | 0.73 (0.50-1.06) | .094 | ||
within 6 months | 0.28 (0.15-0.54) | .0002 | 0.39 (0.23-0.68) | .0009 | ||
within 1 year | 0.60 (0.32-1.13) | .11 | 0.57 (0.36-0.90) | .015 | ||
don’t care | ref | ref | ||||
Comorbidities (Y vs N) | 0.93 (0.59-1.47) | .75 | 0.96 (0.68-1.34) | .79 | ||
Depression/anxiety (Y vs N) | 0.70 (0.44-1.12) | .14 | 0.83 (0.58-1.18) | .30 | ||
Employment | ||||||
Other vs full-time | 1.62 (0.81-3.26) | .18 | 1.44 (0.90-2.30) | .13 | ||
Retired vs full-time | 1.08 (0.56-2.1) | .81 | 1.17 (0.72-1.88) | .53 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.